Delic Holdings Earnings Estimate
Delic Holdings Earnings per Share Projection vs Actual
About Delic Holdings Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Delic Holdings earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Delic Holdings estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Delic Holdings fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Delic Holdings Corp. provides various medicines and treatments in the United States and Canada. In addition, it owns and operates two ketamine infusion treatment clinics and thirteen ketamine infusion treatment clinics. Delic Hldgs operates under Internet Content Information classification in the United States and is traded on OTC Exchange. It employs 116 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Delic Pink Sheet
Delic Holdings financial ratios help investors to determine whether Delic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delic with respect to the benefits of owning Delic Holdings security.